1. Introduction

   • M. F. Michel
   • J. A. A. Hoogkamp-Korstanje

   EditorialNotes Pages: S1 - S1

2. In vitro activity and mode of action of fluoroquinolones

   • L. Verbist

   OriginalPaper Pages: S2 - S10

3. Resistance to quinolones

   • R. P. Mouton

   OriginalPaper Pages: S11 - S15

4. Pharmacokinetics of the newer fluoroquinolones

   • J. R. B. J. Brouwers

   OriginalPaper Pages: S16 - S22

5. Influence of haemodialysis on the pharmacokinetics of ciprofloxacin

   • J. P. Samsom

   OriginalPaper Pages: S23 - S25

6. The activity of ciprofloxacin against Pseudomonas aeruginosa in normal and granulocytopenic mice

   • H. Mattie
   • J. J. Hoogeterp
   • P. Terporten

   OriginalPaper Pages: S26 - S29

7. Comparative activities of five antimicrobial agents in experimental Proteus pyelonephritis in mice

   • P. G. H. Peerbooms
   • D. M. Maclaren

   OriginalPaper Pages: S30 - S32

8. Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro

   • R. Roosendaal
   • I. A. J. M. Bakker-Woudenberg
   • M. F. Michel

   OriginalPaper Pages: S33 - S40

9. Influence of quinolones on throat- and faecal flora of healthy volunteers

   • H. G. de Vries-Hospers
   • G. W. Welling
   • D. van der Waaij

   OriginalPaper Pages: S41 - S44

10. Ciprofloxacin for infection prevention in patients with acute leukemia

    • M. Rozenberg-Arska
    • A. W. Dekker

    OriginalPaper Pages: S45 - S47

11. Long-term oral ciprofloxacin for infection prophylaxis in allogeneic bone marrow transplantation

    • T. de Witte
    • I. Novakova
    • B. de Pauw

    OriginalPaper Pages: S48 - S52

12. Respiratory infections: clinical experiences with the new quinolones

    • B. I. Davies
    • F. P. V. Maesen

    OriginalPaper Pages: S53 - S57

13. Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit

    • D. M. Boland
    • W. C. F. van Gestel
    • D. de Jong

    OriginalPaper Pages: S58 - S59

14. Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin

    • J. A. A. Hoogkamp-Korstange
    • S. J. Klein

    OriginalPaper Pages: S60 - S63

15. Ciprofloxacin for respiratory tract infection with Pseudomonas aeruginosa

    • M. J. Haverkorn

    OriginalPaper Pages: S64 - S67

16. The use of cipfofloxacin in the treatment of patients with cystic fibrosis

    • P. J. Van Den Broek
    • W. Bakker
    • C. Van Gulpen

    OriginalPaper Pages: S68 - S71

17. The influence of the 4- quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline

    • W. J. A. Wijnands
    • T. B. Vree
    • C. L. A. van Herwaarden

    OriginalPaper Pages: S72 - S75

18. Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis

    • H. van Poppel
    • L. Baert

    OriginalPaper Pages: S76 - S77

19. Treatment of chronic bacterial prostatitis with ciprofloxacin

    • T. N. M. Langemeyer
    • W. H. H. Ferwerda
    • T. van der Wal

    OriginalPaper Pages: S78 - S81

20. Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections

    • E. Stolz
    • J. H. T. Wagenvoort
    • A. H. van der Willigen

    OriginalPaper Pages: S82 - S86

21. The use of fluoroquinolones in chronic otitis suppurativa

    • P. H. van de Heyning
    • S. R. Pattyn
    • J. Claes

    OriginalPaper Pages: S87 - S89

22. Treatment of chronic postsurgical osteomyelitis with ciprofloxacin

    • J. A. A. Hoogkamp-Korstanje

    OriginalPaper Pages: S90 - S92

23. Treatment of chronic osteomyelitis with ciprofloxacin

    • J. Stuyck
    • L. Verbist
    • J. C. Mulier

    OriginalPaper Pages: S93 - S96